logo munafa.top

NEWS Gainers Losers
 Learn then Earn

 story : Cytokinetics shares jump based on results from Phase 2 clinical trial for experimental heart-disease drug #FinanceUSA #StockMarketNEWS Shares of Cytokinetics Inc. soared 33.0% in premarket trading

@stockMarketNEWS 10 Days ago

Posted in: #FinanceUSA #StockMarketNEWS

Cytokinetics shares jump based on results from Phase 2 clinical trial for experimental heart-disease drug #FinanceUSA #StockMarketNEWS
Shares of Cytokinetics Inc. soared 33.0% in premarket trading on Monday after the company said a Phase 2 clinical trial for its experimental hypertrophic cardiomyopathy treatment yielded positive results. The still-investigational therapy helped improve blood flow in patients with the disease, which is considered one of the most common reasons for sudden cardiac death in people who are younger than 35. No serious adverse events have been reported in the randomized, placebo-controlled, double-blind trial. Cytokinetics plans to move the therapy into a Phase 3 clinical study sometime this year. The company's stock is down 7.4% so far this year, while the broader S&P 500 is up 15.2%.


Munafa USA Munafa India Munafa NSE


Report

Munafa ebook, learn stock market trading

0 Comments

Sorted by latest first Latest Oldest Best

 Learn then Earn
Back to top | Use Dark Theme